Endovia Health Sciences, Inc. (EDVA) stock
Close on Nov 11, 2026Market cap $130.03KP/E –Yield –
Endovia Health Sciences, Inc. saw revenue fall 90.9% to $73.07K over fiscal 2025. At the latest close the market valued the company at $130.03K.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $130.03K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $73.07K
- Net income
- -$17.28M
- EPS, diluted
- -$25.18
- Book value per share
- -$5.14
- Diluted shares
- 3M
Trading
- Previous close
- $0.17
- Open
- $0.18
- Day's range
- $0.17 – $0.19
- Volume
- 446,043
- Average volume (20 days)
- 547,686
- Beta (5 years)
- 1.03
- 52-week range
- $0.13 – $6.76
- RSI (14 days)
- 48.1
- Volatility (1 year)
- 181.3%
- Relative volume
- 0.12×
- WACC
- 10.0%
Market cap history
Month-end market cap since 2019, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | EDVA | S&P 500 | Difference | EDVA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +11.2% | -2.4% | +13.6 pts | ||
| 3 months | -50.7% | -1.2% | −49.5 pts | ||
| Year to date | -93.7% | +12.3% | −106.0 pts | ||
| 1 year | -96.1% | +12.4% | −108.5 pts | ||
| 3 years | -99.8% | +78.8% | −178.6 pts | -86.8% | +21.4% |
| 5 years | -99.9% | +75.2% | −175.1 pts | -77.4% | +11.9% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Endovia Health Sciences filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Update
- Results
About Endovia Health Sciences
Beverages
Splash Beverage Group, Inc. operates in the consumer beverage industry, focusing on the distribution and management of beverage brands, including alcoholic products. Its principal product offering is Chispo Tequila, an authentic blue agave blanco tequila intended for cocktail mixing. The company operates within a three-tier distribution system, outsourcing distillation and co-packing to third-party contract manufacturers. Its customers include independent local and regional distributors, national retail accounts, and hospitality venues such as restaurant chains.
Company profile, executives and historyEndovia Health Sciences stock: common questions
What is Endovia Health Sciences's stock price?
EDVA closed at $0.17 on Nov 11, 2026, up 2.06% on the day. Over the past 52 weeks it traded between $0.13 and $6.76.
What is Endovia Health Sciences's market cap?
Endovia Health Sciences was worth $130.03K at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is EDVA's P/E ratio?
Endovia Health Sciences lost money over the twelve months to Jun 30, 2026 (diluted EPS -$25.18), so it has no meaningful P/E ratio.
How much revenue does Endovia Health Sciences make?
Endovia Health Sciences reported revenue of $73.07K for fiscal 2025, down 90.9% from a year earlier.
Does Endovia Health Sciences pay a dividend?
No. Endovia Health Sciences has not paid a cash dividend over the last twelve months.
How has EDVA stock performed over the past year?
Including dividends, EDVA returned -96.1% over the past year, against +12.4% for the S&P 500.
Who are Endovia Health Sciences's competitors?
Companies most similar to Endovia Health Sciences by business, industry and size include YHC, RAKR, MDWK, MOJO, IBG.
See a number that looks wrong?